SCHEMBL32669846

SCHEMBL32669846

CN(CC(=O)Nc1ccccc1)C(=O)/C(C#N)=C(\O)c1ccc(O)c([N+](=O)[O-])c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.48
KMT2A Q03164 5/20 0.48
MEN1 O00255 4/20 0.48
MAPT P10636 3/20 0.48
MAPK1 P28482 3/20 0.48
FTO Q9C0B1 3/20 0.48
NPC1 O15118 2/20 0.48
COMT P21964 2/20 0.48
SMN1; SMN2 Q16637 4/20 0.42
HTT P42858 2/20 0.42
RAB9A P51151 1/20 0.42
BCL2L2 Q92843 3/20 0.42
LMNA P02545 1/20 0.42
AURKB Q96GD4 1/20 0.42
POLB P06746 1/20 0.42
LTA4H P09960 1/20 0.41
CYP3A4 P08684 1/20 0.40
TSHR P16473 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30740958 0.90 FTO (0.62) ALDH1A1KMT2AMEN1MAPTMAPK1
SCHEMBL32669944 0.87 FTO (0.53) ALDH1A1KMT2AMEN1MAPTMAPK1
SCHEMBL32669927 0.87 FTO (0.51) ALDH1A1KMT2AMEN1MAPTMAPK1
SCHEMBL32670109 0.86 FTO (0.50) ALDH1A1KMT2AMEN1MAPTMAPK1
SCHEMBL30740938 0.85 FTO (0.48) ALDH1A1KMT2AMEN1MAPTFTO
SCHEMBL32669765 0.82 FTO (0.59) ALDH1A1KMT2AMEN1FTOCOMT
SCHEMBL32669648 0.79 KMT2A (0.51) ALDH1A1KMT2AMEN1MAPTMAPK1
SCHEMBL32669964 0.78 ALDH1A1 (0.41) ALDH1A1KMT2AMEN1HTTLMNA
SCHEMBL32669940 0.78 FTO (0.76) ALDH1A1KMT2AMEN1MAPTMAPK1
SCHEMBL32670106 0.77 FTO (0.49) ALDH1A1KMT2AMEN1FTOCOMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035341-A1 FTO INHIBITORS RPXDS CO LTD (CN) 2026-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035341-A1 FTO INHIBITORS FTO, LDLR, GPR119 ALDH1A1 1334/4885KMT2A 567/4885MEN1 3974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.